
Biodesix Inc
NASDAQ:BDSX

Intrinsic Value
The intrinsic value of one
BDSX
stock under the Base Case scenario is
2.0341
USD.
Compared to the current market price of 0.2767 USD,
Biodesix Inc
is
Undervalued by 86%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Biodesix Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Biodesix Inc
Balance Sheet Decomposition
Biodesix Inc
Current Assets | 29.6m |
Cash & Short-Term Investments | 17.6m |
Receivables | 7.6m |
Other Current Assets | 4.4m |
Non-Current Assets | 56.6m |
PP&E | 28.9m |
Intangibles | 20.4m |
Other Non-Current Assets | 7.3m |
Free Cash Flow Analysis
Biodesix Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Biodesix Inc
Revenue
|
74.5m
USD
|
Cost of Revenue
|
-16.1m
USD
|
Gross Profit
|
58.4m
USD
|
Operating Expenses
|
-90.7m
USD
|
Operating Income
|
-32.4m
USD
|
Other Expenses
|
-8m
USD
|
Net Income
|
-40.4m
USD
|
BDSX Profitability Score
Profitability Due Diligence
Biodesix Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

Score
Biodesix Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.
BDSX Solvency Score
Solvency Due Diligence
Biodesix Inc's solvency score is 26/100. The higher the solvency score, the more solvent the company is.

Score
Biodesix Inc's solvency score is 26/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BDSX Price Targets Summary
Biodesix Inc
According to Wall Street analysts, the average 1-year price target for
BDSX
is 1.836 USD
with a low forecast of 1.515 USD and a high forecast of 2.1 USD.
Dividends
Current shareholder yield for BDSX is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
BDSX
stock under the Base Case scenario is
2.0341
USD.
Compared to the current market price of 0.2767 USD,
Biodesix Inc
is
Undervalued by 86%.